Unlock stock picks and a broker-level newsfeed that powers Wall Street.
22.05
-2.44
(-9.96%)
At close: April 1 at 4:00:01 PM EDT
22.24
+0.19
+(0.86%)
After hours: April 1 at 6:44:28 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 3 |
| Avg. Estimate | -0.28 | -0.35 | -1.71 | -1.29 |
| Low Estimate | -0.44 | -0.49 | -2.09 | -1.61 |
| High Estimate | -0.13 | -0.22 | -1 | -0.82 |
| Year Ago EPS | -0.36 | -0.28 | -1.41 | -1.71 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 7 | 7 |
| Avg. Estimate | 144.61k | 148.78k | 3.46M | 104.27M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 600k | 600k | 20.5M | 230.04M |
| Year Ago Sales | 529k | 111k | 1.14M | 3.46M |
| Sales Growth (year/est) | -72.66% | 34.04% | 203.77% | 2,913.64% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.15 | -0.31 | -0.34 | -0.46 |
| EPS Actual | -0.36 | -0.28 | -0.3 | -0.48 |
| Difference | -0.21 | 0.03 | 0.04 | -0.02 |
| Surprise % | -140.00% | 11.11% | 11.92% | -4.35% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.28 | -0.35 | -1.71 | -1.29 |
| 7 Days Ago | -0.38 | -0.44 | -1.93 | -1.53 |
| 30 Days Ago | -0.38 | -0.44 | -1.93 | -1.39 |
| 60 Days Ago | -0.38 | -0.44 | -1.93 | -1.39 |
| 90 Days Ago | -0.38 | -0.44 | -2.04 | -1.53 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CGON | 21.22% | -26.19% | -21.59% | 24.65% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/31/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/25/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/10/2025 |
| Initiated | TD Cowen: Buy | 1/7/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 12/6/2024 |
Related Tickers
AVBP ArriVent BioPharma, Inc.
18.03
-2.49%
ACLX Arcellx, Inc.
60.70
-7.47%
CNTA Centessa Pharmaceuticals plc
13.23
-8.00%
ENGN enGene Holdings Inc.
4.3300
-3.35%
IDYA IDEAYA Biosciences, Inc.
14.77
-9.83%
UPB Upstream Bio, Inc.
6.70
+9.48%
MAZE Maze Therapeutics, Inc.
9.90
-10.08%
NAMS NewAmsterdam Pharma Company N.V.
18.38
-10.21%
MLTX MoonLake Immunotherapeutics
36.35
-6.96%
RAPP Rapport Therapeutics, Inc.
9.56
-4.69%